Accuitis Pharmaceuticals, Inc. is a US registered company with commercial operations located in Atlanta, GA. Accuitis is a participant in the Georgia Research Alliance Venture Lab program and our key technology was discovered by Emory University. We are engaged in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. Our lead product is a transformational first in class treatment for Rosacea.
Location: United States, Georgia, Alpharetta
Employees: 1-10
Phone: +1 678-812-1492
Total raised: $2M
Founded date: 2011
Investors 2
| Date | Name | Website |
| - | Georgia Re... | gra.org |
| - | GRA Ventur... | graventure... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.08.2018 | - | $1M | - |
| 23.11.2015 | - | $1M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 23.11.2015 | Daily funding roundup - November 23, 2015 | ColorChip raised $25M; Quizlet secured $12M; Sportpursuit received $14.4M funding South Korean apart... | vator.tv/n... |
| 23.11.2015 | Accuitis Closes $1M Financing Round | Accuitis, Inc., a Cumming, GA-based pre-clinical-stage biopharmaceutical company, closed a $1m finan... | finsmes.co... |
| 23.03.2015 | Emory spinout has topical rosacea therapy in the works | The drug works as a proteasome inhibitor. Its mechanism works against the 26S proteasome, which in t... | medcitynew... |
| - | Emory spinout has topical rosacea therapy in the works | Rosacea is common – it impacts 16 million Americans alone – but there’s no cure for the skin reddeni... | medcitynew... |